Archon Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-7,200
Closed -$1.17M 53
2020
Q2
$1.17M Hold
7,200
0.21% 45
2020
Q1
$1.25M Buy
7,200
+800
+13% +$159K 0.27% 45
2019
Q4
$1.28M Hold
6,400
0.22% 49
2019
Q3
$1.35M Hold
6,400
0.26% 45
2019
Q2
$1.24M Hold
6,400
0.25% 48
2019
Q1
$1.05M Sell
6,400
-200
-3% -$35.4K 0.22% 49
2018
Q4
$1.24M Buy
6,600
+1,200
+22% +$222K 0.31% 39
2018
Q3
$919K Buy
5,400
+500
+10% +$84.2K 0.19% 48
2018
Q2
$803K Buy
+4,900
New +$800K 0.17% 52

Other funds holding CME

Archon Partners's CME Position: Q3 2020 in Review

Archon Partners sold out of CME Group (CME) in Q3 2020, closing a stake of 7,200 shares — an estimated $1.17M sold.

Archon Partners first reported a position in CME in Q2 2018 and held it in 9 quarters. The position peaked at $1.35M in Q3 2019. 997 funds tracked by Wall St. Rank hold CME as of Q3 2020.

  • Archon Partners reported no remaining CME Group position as of Q3 2020 after selling out during the quarter.
  • Archon Partners sold 7,200 CME Group shares in Q3 2020, an estimated $1.17M.
  • Archon Partners first reported a position in CME Group in Q2 2018 and held it in 9 quarters.
  • Archon Partners's CME Group position peaked at $1.35M in Q3 2019.
  • 997 funds tracked by Wall St. Rank held CME Group as of Q3 2020.

Based on Archon Partners's 13F filing for Q3 2020, filed 16 Nov 2020.